November 07, 2024
Bangor Daily News

Comments for: Diabetes drug poses high risk, report says

WASHINGTON – A diabetes medicine poised to win Food and Drug Administration approval sharply increases the risk of heart problems, strokes and death, researchers reported Thursday in an analysis that raises pointed new questions about the agency’s handling of drug safety issues. The drug, Pargluva,… Read More

You may also like